Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7086-7086
2005 ◽
Vol 11
(10)
◽
pp. 3750-3757
◽
2005 ◽
Vol 11
(6)
◽
pp. 2106-2110
◽
2005 ◽
Vol 11
(21)
◽
pp. 7960-7961
◽
2005 ◽
Vol 11
(12)
◽
pp. 4289-4294
◽
2007 ◽
Vol 67
(11)
◽
pp. 5267-5274
◽
2008 ◽
Vol 3
(8)
◽
pp. 832-839
◽